Literature DB >> 1327749

Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging.

O Donzé1, P F Spahr.   

Abstract

The Rous sarcoma virus (RSV) RNA leader sequence carries three open reading frames (uORFs) upstream of the AUG initiator of the gag gene. We studied, in vivo, the role of these uORFs by changing two or three nucleotides of the three AUGs or by deleting the first uORF. Our results show that (i) unlike most previously characterized uORFs, which decrease translation, the first uORF (AUG1) of RSV acts as an enhancer of translation, since absence of the first AUG decreased translation; AUG3 also modulates translation, probably by interfering with scanning ribosomes as described for other upstream ORFs, and mutation of AUG2 had no effect on translation. (ii) Mutation of each of the upstream AUGs lowered the infectivity of progeny virions. (iii) Unexpectedly, mutation of AUG1 and/or AUG3 dramatically reduced RNA packaging by 50-to 100-fold, unlike mutation of AUG2 which did not alter RNA packaging efficiency. Additional mutants in the vicinity of uORF1 and uORF3 were constructed in order to elucidate the mechanism by which uORFs affect RNA packaging: a translation model requiring uORFs 1 and 3, and involving ribosome pausing at AUG 3 is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327749      PMCID: PMC556835          DOI: 10.1002/j.1460-2075.1992.tb05460.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  A mutation in the short 5'-proximal open reading frame on Rous sarcoma virus RNA alters virus production.

Authors:  R B Petersen; A Moustakas; P B Hackett
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  Mutational analysis of upstream AUG codons of poliovirus RNA.

Authors:  J Pelletier; M E Flynn; G Kaplan; V Racaniello; N Sonenberg
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Synthesis in vitro of a seven amino acid peptide encoded in the leader RNA of Rous sarcoma virus.

Authors:  P B Hackett; R B Petersen; C H Hensel; F Albericio; S I Gunderson; A C Palmenberg; G Barany
Journal:  J Mol Biol       Date:  1986-07-05       Impact factor: 5.469

5.  Translational regulation of SV40 early mRNA defines a new viral protein.

Authors:  K Khalili; J Brady; G Khoury
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

6.  Production of single-stranded plasmid DNA.

Authors:  J Vieira; J Messing
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Participation of 5'-terminal leader sequences in in vitro translation of Rous sarcoma virus RNA.

Authors:  M L Perdue; D Borchelt; R J Resnick
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

8.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

9.  Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region.

Authors:  B A Arrick; A L Lee; R L Grendell; R Derynck
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  35 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal.

Authors:  J D Banks; M L Linial
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  In vitro characterization of a base pairing interaction between the primer binding site and the minimal packaging signal of avian leukosis virus genomic RNA.

Authors:  Igor Kanevsky; Natalya Vasilenko; Hélène Dumay-Odelot; Philippe Fossé
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

6.  Rice tungro bacilliform virus open reading frames II and III are translated from polycistronic pregenomic RNA by leaky scanning.

Authors:  J Fütterer; H M Rothnie; T Hohn; I Potrykus
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.

Authors:  J T Miller; Z Ge; S Morris; K Das; J Leis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression.

Authors:  A Moustakas; T S Sonstegard; P B Hackett
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal.

Authors:  N A Doria-Rose; V M Vogt
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

10.  Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.

Authors:  Jing Zhou; Rebecca L Bean; Volker M Vogt; Michael Summers
Journal:  J Mol Biol       Date:  2006-10-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.